Hyperkalemia Treatment Market– Dynamics
Increase in prevalence of cardiac arrhythmias and chronic kidney disease are major factors driving growth of hyperkalemia treatment market during the forecast period. According to Centers for Disease Control and Prevention (CDC) report, in 2017 around 30 million or 15% people suffer from chronic kidney diseases in the U.S. Increasing number of people suffering from lifestyle-associated diseases also leads to high prevalence of hyperkalemia, which in turn boost growth of the market.
Hyperkalemia Treatment Market Report Snapshots
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients